This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sutton-Tyrrell, K. Articles by Kuller, L. H. Search for Related Content PubMed PubMed Citation Articles by Sutton-Tyrrell, K. Articles by Kuller, L. H.

Stroke, Vol 25, 44-50, Copyright © 1994 by American Heart Association

ARTICLES

Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic hypertension

K Sutton-Tyrrell, SK Wolfson Jr and LH Kuller
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA 15261.

BACKGROUND AND PURPOSE--The Systolic Hypertension in the Elderly Program (SHEP) was a randomized trial testing the efficacy of treating systolic hypertension in older adults. A significant reduction in stroke risk was observed among participants assigned to active treatment. Serial carotid duplex scans were performed on 129 participants at the University of Pittsburgh center, and rates of progression and regression of carotid stenosis were observed. METHODS-- Changes in blood flow velocity ratios were used to detect progression because they can be reliably measured and their relation to degree of residual lumen is known. Progression required the development of a 40% to 50% diameter stenosis when stenosis was not initially present or, if already present, further reduction in the lumen diameter. Regression required the absence of a 40% to 50% diameter stenosis when stenosis was initially present or a stenosis significantly less severe than that initially seen. RESULTS--Progression occurred in 22% (28/129) of participants and regression in 16% (8/49). Progression of carotid stenosis occurred more often among participants randomized to placebo as compared with active treatment (31% versus 14%, P = .020). All eight patients exhibiting-regression were randomized to active treatment. In multivariate analysis, participants assigned to placebo had 4.3 times greater odds of progressing than participants assigned to active treatment. Other factors significantly related to progression were higher degree of plaque at baseline, low high-density lipoprotein-3, high lipoprotein(a), and younger age. CONCLUSIONS--Treating systolic hypertension appears to slow progression of carotid stenosis. Similar effects occurring in the intracranial vessels may be one reason for the substantial decrease in stroke among SHEP participants assigned to active treatment.

This article has been cited by other articles:

				K. Sutton-Tyrrell, R. Wildman, A. Newman, and L. H. Kuller Extent of Cardiovascular Risk Reduction Associated With Treatment of Isolated Systolic Hypertension Arch Intern Med, December 8, 2003; 163(22): 2728 - 2731. [Abstract] [Full Text] [PDF]

				C. D. Liapis, J. D. Kakisis, and A. G. Kostakis Carotid Stenosis: Factors Affecting Symptomatology Stroke, December 1, 2001; 32(12): 2782 - 2786. [Abstract] [Full Text] [PDF]

				T. A. Lakka, R. Salonen, G. A. Kaplan, and J. T. Salonen Blood Pressure and the Progression of Carotid Atherosclerosis in Middle-Aged Men Hypertension, July 1, 1999; 34(1): 51 - 56. [Abstract] [Full Text] [PDF]

				M. Hirschl, M. Kundi, and G. Blazek Five-Year Follow-up of Patients After Thromboendarterectomy of the Internal Carotid Artery: Relevance of Baroreceptor Sensitivity Stroke, July 1, 1996; 27(7): 1167 - 1172. [Abstract] [Full Text]

				M. Suurkula, S. Agewall, B. Fagerberg, I. Wendelhag, and J. Wikstrand Multiple Risk Intervention in High-Risk Hypertensive Patients : A 3-Year Ultrasound Study of Intima-Media Thickness and Plaques in the Carotid Artery Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 462 - 470. [Abstract] [Full Text]

				M. Cortellaro, D. Baldassarre, E. Cofrancesco, E. Tremoli, A. Colombo, C. Boschetti, and R. Paoletti Relation Between Hemostatic Variables and Increase of Common Carotid Intima-Media Thickness in Patients With Peripheral Arterial Disease Stroke, March 1, 1996; 27(3): 450 - 454. [Abstract] [Full Text]

				A. Delcker, H.C. Diener, and H. Wilhelm Influence of Vascular Risk Factors for Atherosclerotic Carotid Artery Plaque Progression Stroke, November 1, 1995; 26(11): 2016 - 2022. [Abstract] [Full Text]

				J. R. Crouse III, T. E. Craven, A. P. Hagaman, and M. G. Bond Association of Coronary Disease With Segment-Specific Intimal-Medial Thickening of the Extracranial Carotid Artery Circulation, September 1, 1995; 92(5): 1141 - 1147. [Abstract] [Full Text]

				L.H. Kuller, L. Shemanski, B.M. Psaty, N.O. Borhani, J. Gardin, M.N. Haan, D.H. O'Leary, P.J. Savage, G.S. Tell, and R. Tracy Subclinical Disease as an Independent Risk Factor for Cardiovascular Disease Circulation, August 15, 1995; 92(4): 720 - 726. [Abstract] [Full Text]

				K. Sutton-Tyrrell, H. G. Alcorn, H. Herzog, S. F. Kelsey, and L. H. Kuller Morbidity, Mortality, and Antihypertensive Treatment Effects by Extent of Atherosclerosis in Older Adults With Isolated Systolic Hypertension Stroke, August 1, 1995; 26(8): 1319 - 1324. [Abstract] [Full Text]

				P. B. Gorelick Stroke Prevention Arch Neurol, April 1, 1995; 52(4): 347 - 355. [Abstract] [PDF]